{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:15:59Z","timestamp":1769940959074,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.7759\/cureus.102735","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:43:03Z","timestamp":1769892183000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factor Control in a Portuguese Vascular Risk Clinic: A 16-Month Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Cristiano","family":"Gante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Tsisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Catarina","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Salvado de Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds R","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cardiovascular diseases (CVDs). (2025). https.\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-%28cvds%29."},{"key":"ref2","unstructured":"Cardiovascular diseases. (2024). https.\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/cardiovascular-diseases."},{"key":"ref3","unstructured":"Cardiovascular Disease Scorecards - Portugal. (2023). https.\/\/world-heart-federation.org\/wp-content\/uploads\/WHF_SCORECARD-2024-Portugal.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby P","year":"2005","unstructured":"Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005, 111:3481-8. 10.1161\/CIRCULATIONAHA.105.537878","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","unstructured":"SCORE2 risk prediction algorithms. new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021, 42:2439-54. 10.1093\/eurheartj\/ehab309","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","unstructured":"SCORE2-OP risk prediction algorithms. estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021, 42:2455-67. 10.1093\/eurheartj\/ehab312","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2018.09.011","article-title":"Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: the PRECISE study","volume":"38","author":"da Silva PM","year":"2019","unstructured":"da Silva PM, Lima MJ, Neves PM, de Macedo ME. Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: the PRECISE study. Rev Port Cardiol (Engl Ed). 2019, 38:427-37. 10.1016\/j.repc.2018.09.011","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2022.04.011","article-title":"High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: the PICT2RE observational study","volume":"42","author":"Cardoso H","year":"2023","unstructured":"Cardoso H, Bello CT, Andrade L, et al.. High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: the PICT2RE observational study. Rev Port Cardiol. 2023, 42:319-30. 10.1016\/j.repc.2022.04.011","journal-title":"Rev Port Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2022.11.008","article-title":"Review on the management of cardiovascular risk factors in the elderly","volume":"19","author":"Harmand MG","year":"2022","unstructured":"Harmand MG, Garc\u00eda-Sanz MD, Agust\u00ed A, et al.. Review on the management of cardiovascular risk factors in the elderly. J Geriatr Cardiol. 2022, 19:894-927. 10.11909\/j.issn.1671-5411.2022.11.008","journal-title":"J Geriatr Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac395","article-title":"Hypertension management in patients with cardiovascular comorbidities","volume":"44","author":"Lauder L","year":"2023","unstructured":"Lauder L, Mahfoud F, Azizi M, et al.. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023, 44:2066-77. 10.1093\/eurheartj\/ehac395","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)","volume":"34","author":"Ryd\u00e9n L","year":"2013","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD, et al.. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013, 34:3035-87. 10.1093\/eurheartj\/eht108","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock G","year":"2009","unstructured":"Whitlock G, Lewington S, Sherliker P, et al.. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009, 373:1083-96. 10.1016\/S0140-6736(09)60318-4","journal-title":"Lancet"},{"key":"ref15","unstructured":"Tobacco. key facts. (2025). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451301-risk-factor-control-in-a-portuguese-vascular-risk-clinic-a-16-month-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:43:06Z","timestamp":1769892186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451301-risk-factor-control-in-a-portuguese-vascular-risk-clinic-a-16-month-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.102735","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}